These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 6983249)

  • 21. First report of lymphatic mapping with isosulfan blue dye and sentinel node biopsy in cervical cancer.
    Medl M; Peters-Engl C; Schütz P; Vesely M; Sevelda P
    Anticancer Res; 2000; 20(2B):1133-4. PubMed ID: 10810409
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MR lymphangiography for the assessment of the lymphatic system in patients undergoing microsurgical reconstructions of lymphatic vessels.
    Lohrmann C; Felmerer G; Foeldi E; Bartholomä JP; Langer M
    Microvasc Res; 2008 May; 76(1):42-5. PubMed ID: 18456290
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Factitious oxygen desaturation after isosulfan blue injection.
    Heinle E; Burdumy T; Recabaren J
    Am Surg; 2003 Oct; 69(10):899-901. PubMed ID: 14570371
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fluorescein labeling of lymphatic vessels for lymphangiography.
    Cooper SG; Maitem AN; Richman AH
    Radiology; 1988 May; 167(2):559-60. PubMed ID: 3357973
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Occurrence of prolonged injection site mass with methylene blue but not isosulfan blue after the sentinel node procedure.
    Shirah GR; Bouton ME; Komenaka IK
    Arch Surg; 2011 Feb; 146(2):137-41. PubMed ID: 21339422
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intradermal radioisotope is superior to peritumoral blue dye or radioisotope in identifying breast cancer sentinel nodes.
    Lin KM; Patel TH; Ray A; Ota M; Jacobs L; Kuvshinoff B; Chung M; Watson M; Ota DM
    J Am Coll Surg; 2004 Oct; 199(4):561-6. PubMed ID: 15454139
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The relative false negative rate of isosulfan blue in detecting sentinel lymph nodes in early breast cancer.
    Kantaraksa N; Kongdan Y; Suvikapakornkul R; Wasutit Y; Chirappapha P; Lertsithichai P
    J Med Assoc Thai; 2012 Feb; 95(2):181-5. PubMed ID: 22435247
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regarding "Treatment of postoperative high-volume lymphatic complications using isosulfan blue".
    Fisher JA; Bundy JJ; Gemmete JJ; Srinivasa RN; Chick JFB
    J Vasc Surg Venous Lymphat Disord; 2019 Mar; 7(2):309-310. PubMed ID: 30771835
    [No Abstract]   [Full Text] [Related]  

  • 29. Anaphylactoid reactions to isosulfan blue dye during breast cancer lymphatic mapping in patients given preoperative prophylaxis.
    Raut CP; Daley MD; Hunt KK; Akins J; Ross MI; Singletary SE; Marshall GD; Meric-Bernstam F; Babiera G; Feig BW; Ames FC; Kuerer HM
    J Clin Oncol; 2004 Feb; 22(3):567-8. PubMed ID: 14752082
    [No Abstract]   [Full Text] [Related]  

  • 30. Adverse drug reactions during lymphatic mapping and sentinel lymph node biopsy for solid neoplasms.
    Amr D; Broderick-Villa G; Haigh PI; Guenther JM; DiFronzo LA
    Am Surg; 2005 Sep; 71(9):720-4. PubMed ID: 16468505
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Methylene blue dye--a safe and effective alternative for sentinel lymph node localization.
    Varghese P; Abdel-Rahman AT; Akberali S; Mostafa A; Gattuso JM; Carpenter R
    Breast J; 2008; 14(1):61-7. PubMed ID: 18186867
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lymphangiography of the mouse ear.
    Jain RK; Munn LL; Fukumura D
    Cold Spring Harb Protoc; 2012 Nov; 2012(11):1179-80. PubMed ID: 23118365
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A prospective analysis of the effect of blue-dye volume on sentinel lymph node mapping success and incidence of allergic reaction in patients with breast cancer.
    King TA; Fey JV; Van Zee KJ; Heerdt AS; Gemignani ML; Port ER; Sclafani L; Sacchini V; Petrek JA; Cody HS; Borgen PI; Montgomery LL
    Ann Surg Oncol; 2004 May; 11(5):535-41. PubMed ID: 15123464
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dynamic imaging of lymphatic vessels and lymph nodes using a bimodal nanoparticulate contrast agent.
    Mounzer R; Shkarin P; Papademetris X; Constable T; Ruddle NH; Fahmy TM
    Lymphat Res Biol; 2007; 5(3):151-8. PubMed ID: 18035933
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MR imaging of the lymphatic system in patients with lipedema and lipo-lymphedema.
    Lohrmann C; Foeldi E; Langer M
    Microvasc Res; 2009 May; 77(3):335-9. PubMed ID: 19323976
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel lymphography using indocyanine green dye for near-infrared fluorescence labeling.
    Ogata F; Azuma R; Kikuchi M; Koshima I; Morimoto Y
    Ann Plast Surg; 2007 Jun; 58(6):652-5. PubMed ID: 17522489
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fluorescence microlymphography: diagnostic potential in lymphedema and basis for the measurement of lymphatic pressure and flow velocity.
    Bollinger A; Amann-Vesti BR
    Lymphology; 2007 Jun; 40(2):52-62. PubMed ID: 17853615
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Optimizing the outcome of microsurgical subinguinal varicocelectomy using isosulfan blue: a prospective randomized trial.
    Schwentner C; Oswald J; Lunacek A; Deibl M; Bartsch G; Radmayr C
    J Urol; 2006 Mar; 175(3 Pt 1):1049-52. PubMed ID: 16469616
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Current value of lymphography].
    Gimeno Solsona F; Cot Martínez X
    Rev Clin Esp; 1981 Dec; 163(5):327-9. PubMed ID: 7342190
    [No Abstract]   [Full Text] [Related]  

  • 40. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.